Quantitative determination of antibodies to type III group B streptococcal polysaccharide

Journal of Infectious Diseases

Volumn 173, Issue 1, 1996, Pages 142-150

  Guttormsen, Hilde Kari ^a   Baker, Carol J ^b   Edwards, Morven S ^b   Paoletti, Lawrence C ^b   Kasper, Dennis L ^b  

^a CHANNING LABORATORY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN EXPERIMENT; MOUSE; NEWBORN INFECTION; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS AGALACTIAE;

EID: 0030023541     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.1.142     Document Type: Article

References (11)

1. Baker C, Edwards MS. Group B streptococcal infections. Perinatal impact and prevention methods. Ann NY Acad Sci 1988;549:193-202.
2. Ferrieri P. Neonatal susceptibility and immunity to major bacterial pathogens. Rev Infect Dis 1990;12(suppl 4):394-400.
3. Kogan G, Uhrin D, Brisson JR, et al. Structure of the type VI group B Streptococcus capsular polysaccharide determined by high resolution NMR spectroscopy. J Carbohydr Chem 1994;13:1071-8.
4. Kogan G, Uhrin D, Brisson JR, et al. Structural and immunochemical characterization of the novel type VIII group B Streptococcus capsular polysaccharide (abstract A1.10). In: Program and abstracts of the XVII International Carbohydrate Symposium (Ottawa). Ottawa: National Research Council Canada, 1994:44.
5. Wessels MR, DiFabio JL, Benedi VJ, et al. Structural determination and immunochemical characterization of the type V group B Streptococcus capsular polysaccharide. J Biol Chem 1991;266:6714-9.
6. von Hunolstein C, Parisi L, D'Ascenzi S, et al. Streptococcus agalactiae nontypable strain 7271, new type candidate: type polysaccharide characterization and pathogenicity for mice [abstract B-186]. In: Program and abstracts of the 93rd meeting of the American Society for Microbiology (Atlanta). Washington, DC: ASM, 1993:59.
7. Blumberg HM, Modansky M, Stephens DS, et al. Emergence of invasive serotype V group B streptococcal disease [abstract 298A]. Clin Res 1994;42:298A.
8. Baker CJ, Goroff DK, Alpert SL, Hayes C, McCormack WM. Comparison of bacteriological methods for the isolation of group of B Streptococcus from vaginal cultures. J Clin Microbiol 1976;4:46-8.
9. Baker CJ, Kasper DL, Tager IB, et al. Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus. J Clin Invest 1977;59:810-8.
10. Anderson DC, Edwards MS, Baker CJ. Luminol-enhanced chemiluminescence for evaluation of type III group B streptococcal opsonins in human sera. J Infect Dis 1980;141:370-81.
11. Baker CJ, Edwards MS, Kasper DL. Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. Pediatrics 1981;68:544-9.